Study to Analyze Mutations in V600 BRAF Oncogen in Participants With Metastatic Melanoma

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Metastatic Cancers Clinical Trial

Official title:
Epidemiological Study of V600 BRAF Mutation in Spanish Patients Diagnosed With Metastatic Melanoma: ABSOLUT-BRAF Study

Status Completed

Clinical Trial Summary

This is a national, multicenter, cross-sectional epidemiological study in adult Spanish participants diagnosed with advanced or metastatic melanoma.

n/a

See also
Status	Clinical Trial	Phase
Suspended	`NCT01723306` - Phase II/Pilot Study of 2nd Generation Anti-CEA Designer T Cells in Adenocarcinomas	Phase 2
Active, not recruiting	`NCT02304809` - Phase 2 Study Assessing Secured Access to Vemurafenib for Patients With Tumors Harboring BRAF Genomic Alterations	Phase 2
Recruiting	`NCT02155621` - Personalized Oncogenomics (POG) Program of British Columbia	N/A
Completed	`NCT02303990` - RADVAX: A Stratified Phase I Trial of Pembrolizumab With Hypofractionated Radiotherapy in Patients With Advanced and Metastatic Cancers	Phase 1
Recruiting	`NCT06085716` - Combination Therapy for Cancer Related Fatigue in Patients With Metastatic Cancers	Phase 2/Phase 3
Completed	`NCT02701907` - EXPRESS: EXcePtional RESponSe - Exceptional and Unexpected Response to Targeted Therapies	N/A
Terminated	`NCT02376933` - Vertebral Augmentation and Radiotherapy of Collapse Spinal Metastatic Cancer	N/A